ArticlePloS one2015
The Impacts of Migraine among Outpatients with Major Depressive Disorder at a Two-Year Follow-Up.
Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 23 citations in OpenAlex.
- Risk of major mental disorders in the offspring of parents with migraine.Annals of general psychiatry · 2024Article
- Transient visual disturbances are associated with disability and suicide risk in patients with migraine without aura.Journal of the Chinese Medical Association : JCMA · 2023Article
- Review
- Comparing the associations of three psychometric scales at baseline with long-term prognosis of depression over a 10-year period.International journal of methods in psychiatric research · 2022Article
- Omega-3 Polyunsaturated Fatty Acids Supplementation Alleviate Anxiety Rather Than Depressive Symptoms Among First-Diagnosed, Drug-Naïve Major Depressive Disorder Patients: A Randomized Clinical Trial.Frontiers in nutrition · 2022Article
- Migraine associated with early onset postpartum depression in women with major depressive disorder.Archives of women's mental health · 2021Article
- Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas.Scientific reports · 2021Article
- Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression.The international journal of neuropsychopharmacology · 2020Article
- The exploration of mechanisms of comorbidity between migraine and depression.Journal of cellular and molecular medicine · 2019Review
- Article
- Reliability and validity of the Depression and Somatic Symptoms Scale among patients with chronic low back pain.Neuropsychiatric disease and treatment · 2019Article
- Migraine and greater pain symptoms at 10-year follow-up among patients with major depressive disorder.The journal of headache and pain · 2018Article
- Article
- Comorbid pain and migraine chronicity: The Chronic Migraine Epidemiology and Outcomes Study.Neurology · 2017Article
- Roads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine Pathology.Frontiers in immunology · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNo study has investigated the impacts of migraine on depression, anxiety, and somatic symptoms and remission at the two-year follow-up point among patients with major depressive disorder (MDD). This study aimed to investigate the above issues.
methodsPsychiatric outpatients with MDD recruited at baseline were investigated at a two-year follow-up (N = 106). The Hamilton Depression Rating Scale, Hospital Anxiety and Depression Scale, and Depression and Somatic Symptoms Scale were used. Migraine was diagnosed according to the International Classification of Headache Disorders, 2nd edition. The patients were divided into no migraine, inactive migraine, and active migraine subgroups. Multiple logistic regressions were used to investigate the significant factors related to full remission of depression.
resultsAmong patients without pharmacotherapy at the follow-up, patients with active migraine had significantly greater severities of anxiety and somatic symptoms as compared with patients without migraine; moreover, patients with active migraine had the lowest improvement percentage and full remission rate. There were no significant differences in depression, anxiety, and somatic symptoms between patients with inactive migraine and those without migraine. Active headache at follow-up was a significant factor related to a lower full remission rate.
conclusionsActive headache at follow-up was associated with a lower rate of full remission and more residual anxiety and somatic symptoms at follow-up among patients with migraine. Physicians should integrate a treatment plan for depression and migraine for the treatment of patients with MDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.